Prev：inery defines disease progression, therapeutic response and pharmacogenomic landscape in hepatocellular carcinoma(KTA2011-37.3)
Next：Clinical, genetic, and molecular characteristics in a central‐southern Chinese cohort of genetic leukodystrophies(A23420-5.3)
